Treatment Options for Molluscum Contagiosum
The most effective first-line treatment for bothersome molluscum contagiosum is cryotherapy with liquid nitrogen, which has a 93.3% complete response rate, or cantharidin application which is well-tolerated and effective, particularly in children. 1
Treatment Algorithm
First-Line Options:
For asymptomatic, limited lesions in immunocompetent patients:
- Observation for spontaneous resolution with monitoring for 3-6 months 1
- Cover visible lesions with clothing/bandages to prevent spread
For bothersome, extensive, or symptomatic lesions:
Second-Line Options:
Surgical options:
- Curettage or excision
- Tangential scissor excision
- Shave excision
- Electrosurgery (for larger lesions) 1
Chemical treatments:
Important Considerations
Efficacy of Treatments
| Treatment | Efficacy | Potential Complications |
|---|---|---|
| Cryotherapy | 93.3% complete response | Pain, necrosis, blistering, hyperpigmentation |
| Cantharidin | High efficacy | Minimal side effects |
| 10% KOH | 86.6% complete response | Mild irritation |
Special Populations
Children:
- Avoid painful treatments in young children when possible 1
- Cantharidin is particularly well-tolerated in children 2
- Important note: Imiquimod is NOT recommended as randomized controlled trials have shown it is not more effective than placebo 1 and FDA labeling confirms this lack of efficacy in pediatric studies 3
Near-Eye Lesions:
- Prompt treatment is recommended to prevent conjunctivitis 1
Immunocompromised Patients:
- Evaluation for immunocompromised state should be considered in adults with large and multiple lesions 1
Prevention of Spread
- Cover visible lesions with clothing or bandages
- Maintain good hand hygiene, especially after touching lesions
- Avoid sharing personal items like towels and clothing
- Avoid scratching or picking at lesions to prevent autoinoculation 1
Common Pitfalls to Avoid
Using imiquimod as treatment - Despite its common use, clinical studies have demonstrated it is not more effective than placebo for molluscum contagiosum 1, 3
Failing to identify and treat nascent lesions - This increases recurrence risk 1
Overlooking associated conditions - Patients with atopic dermatitis may develop more widespread involvement 4
Ignoring prevention measures - Essential to provide guidance on preventing spread through avoiding touching lesions and intimate contact until resolution 1
Using painful treatments in young children - Can cause unnecessary trauma when less painful options are available 1
The recent FDA approval of YCANTH™ (cantharidin 0.7%) topical solution provides a standardized formulation for treating molluscum contagiosum in children (≥2 years) and adults, with demonstrated efficacy in phase-3 trials 5.